1Bedir A, Topbas M, Tanyeri F, et al. Leptin might be a regulator of serum uric acid concentrations in humans[J]. Jpn Heart J,2003, 44(4): 527-536.
2Tamakoshi K, Yatsuya H, Kondo T, et al. The metabolic syndrome is associated with elevated circulting C-reactive protein in healthy reference range,a systemic low-grade inflammatory state[J].Int J Obes Relat Disord, 2003, 27(4): 443-449.
3Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early at herosclerotic lesions of human coronary arteries[J]. Arterioscler Thromb Vase Biof, 1998, 18: 386-392.
6[2]Cardillo C, Panza JA. Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vasc Med, 1998,3(2):138
7[4]Shandelya SML, Kuppusamy P, Weisfeldt ML, et al. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion in jury evidence for plasms-mediated leukocyte activation. Circulation, 1993,87:536
8[5]Lucchesi BR. Myocardial ischemia, reperfusion and free radical injury. Am J Cardiol, 1990, 65:141
9Omboni S, Parati G, Zanchetti A, et al. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens, 1995 ; 13:1105-- 1112.
10Frohlich ED. Current clinical pathophysiologic considerations in essential hypertension[J] Med Clini N Am, 1997 ; 81 (5) : 1124.
4Chem PH. Role of oxidants in ischemic damage[J]. Stroke, 1996,27 (6):1124.
5RIDKER PM, GLYNN R J, HENNEKEN CH. C-reactive protein adds to the predictive value of total and HDL cholesteroi in determining risk of first myocardial infarction[J]. Circulation, 1998,97:2007-2011.
6BAUTISA LE, LOPEZ-JARA MILL P, VERA LM, et al. Is C-reactive protein an independent risk factor for essential hypertension[J]. J Hypertents, 2001, 19(5): 857-861.
